Passage Bio Inc reports results for the quarter ended in March - Earnings Summary

Passage Bio

16/05/2022 14:32

* Passage Bio Inc  PASG.OQ  reported a quarterly adjusted
loss
of 79 cents​​ per share for the quarter ended in March. The mean
expectation of nine analysts for the quarter was for a loss
of 89 cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * Passage Bio Inc's reported EPS for the quarter was a loss
of 79
cents​.
    * The mean earnings estimate of analysts had fallen by
about 1.9%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Passage Bio Inc shares had fallen by 41.0% this
quarter and
lost 71.2% so far this year.
    * The company reported a quarterly loss of $42.81 million.
    * Wall Street's median 12-month price target for Passage Bio
Inc
is $16.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 16 at 01:32 p.m.  ​All
figures in US dollars unless otherwise stated